— Know what they know.
Not Investment Advice
Also trades as: CANF.TA (TLV) · $vol 0M

CANF AMEX

Can-Fite BioPharma Ltd.
1W: -11.1% 1M: -24.7% 3M: -47.5% YTD: -61.8% 1Y: -81.7% 3Y: -95.9% 5Y: -99.5%
$1.65
-0.07 (-4.07%)
 
Weekly Expected Move ±6.8%
$2 $2 $2 $2 $2
AMEX · Healthcare · Biotechnology · Tech Score Strong Sell · Power 24 · $2.2M mcap · 122M float · 1.01% daily turnover · Short 30% of daily vol
Credit Risk of going bust: higher than 63% of companies Debt: 2.2% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.01 (down 99.5%), Can-Fite BioPharma Ltd. would be worth roughly what it owes.
Total debt $49K against a stock market value of $2.2M.
Distance to default 4.00 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $24K (short-term plus half of long-term), stock volatility 101.7%; Altman Z'' -75.24. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Oct Typical
⛈️
Stormy
-32.4% YTD avg
Midterm Year
⛈️
Stormy
-38.6% YTD avg
2026 Now
⛈️
Stormy
Below typical
20yr Avg YTD
-32.4%
Day 206 of 252
Midterm Year YTD
-38.6%
Presidential cycle avg
2026 YTD
-61.8%
Below 20yr avg
Typical Vol
69%
Annualized
Monthly Weather Forecast
Jan
20yr
⛈️
-8.8%
Midterm
⛅
+3.4%
29% win 74% vol
Feb
20yr
🌫️
-12.0%
Midterm
🌧️
-4.1%
57% win 80% vol
Mar
20yr
⛈️
-17.0%
Midterm
⛈️
-13.5%
43% win 110% vol
Apr
20yr
⛈️
-24.6%
Midterm
⛈️
-21.6%
29% win 92% vol
May
20yr
⛈️
-26.8%
Midterm
⛈️
-29.8%
43% win 72% vol
Jun
20yr
⛈️
-27.4%
Midterm
⛈️
-33.6%
29% win 63% vol
Jul
20yr
⛈️
-28.9%
Midterm
⛈️
-35.6%
36% win 87% vol
Aug
20yr
⛈️
-32.4%
Midterm
⛈️
-30.9%
36% win 56% vol
Sep
20yr
💨
-31.4%
Midterm
⛈️
-37.4%
36% win 128% vol
Oct
20yr
⛈️
-34.1%
Midterm
⛈️
-37.4%
29% win 69% vol
Now: -23.6%
Nov
20yr
💨
-32.5%
Midterm
⛈️
-28.6%
57% win 86% vol
Dec
20yr
⛈️
-10.1%
Midterm
⛈️
-15.8%
21% win 117% vol
Seasonality (20yr)
Updated: 2026-10-27
YTD: -61.8%

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms